CHAMPIONS ONCOLOGY, INC.

Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.

CSBR | NDAQ

Overview

Corporate Details

ISIN(s):: US15870P3073
LEI:: 549300O8WKLP8QEG5U47
Country:: United States of America
Address:: 855 N. WOLFE STREET, 21205 BALTIMORE
Website:: https://championsoncology.com
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Champions Oncology, Inc. is a global contract research organization (CRO) specializing in end-to-end oncology drug development solutions. The company partners with pharmaceutical and biotech firms to accelerate research from discovery to clinical success. Its core offerings are built upon a proprietary, clinically relevant bank of over 1,400 patient-derived xenograft (PDX) models. This is integrated with a comprehensive multi-omic data platform, containing over two billion data points, accessible through its Lumin software for advanced analytics and visualization. Champions provides a suite of preclinical and clinical specialty testing services, including high-complexity flow cytometry, next-generation sequencing, histology, and radiopharmaceutical development, enabling data-driven decisions and biomarker discovery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CHAMPIONS ONCOLOGY, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHAMPIONS ONCOLOGY, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for CHAMPIONS ONCOLOGY, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.	United States of America	CRL
Ch. Charilaou Group Plc A tour operator selling travel packages and developing online reservation platform solutions.	Cyprus	CHCH
Cheil Worldwide Inc Creates data-driven, integrated marketing and connected experiences for global brands.	South Korea	030000
Chiome Bioscience Inc. Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.	Japan	4583
Chordia Therapeutics,Inc Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.	Japan	190A
CHOSA Oncology AB Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.	Sweden	CHOSA
Cidara Therapeutics, Inc. Developing drug-Fc conjugates as targeted immunotherapies for cancer and serious infections.	United States of America	CDTX
CINC Corp. Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.	Japan	4378
CIRCULATION Co.,Ltd. Connects corporations with experts for project-based consulting to solve business challenges.	Japan	7379
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Developing a CIZ1B biomarker blood test for the early detection of lung cancer.	United Kingdom	CIZ